Developing Drug Strategies for the Neuroprotective Treatment: 2nd Edition

Dear Colleagues,

Neurological disorders are a major public health problem that constitutes more than 6% of the global burden of disease. Among diseases of the central and peripheral nervous systems, the most common neurological disorders are epilepsy, Alzheimer's disease, multiple sclerosis, cerebrovascular diseases, Parkinson's disease, and traumatic disorders. The main pathogenesis mechanism of neurological disorders is the abnormality or death of brain cells caused by excitotoxic effects, the disturbance of cellular energy metabolism, and oxidative stress. However, the pharmacological treatment of neurological disorders faces many challenges. Firstly, the available and currently used drugs do not provide a cure. Secondly, they are also associated with toxicity and adverse reactions. Hence, the development of newer and safer neuroprotective drugs has become a major goal. The purpose of this Special Issue of Molecules is to collect original research articles and reviews on the potential strategies for the treatment of neurological disorders.

Prof. Dr. Su-Jane Wang
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• neurological disease
• neuroprotectant
• drug discovery
• chemical synthesis
• natural products
• drug targeting

• Developing Drug Strategies for the Neuroprotective Treatment in Molecules (8 articles)